论文信息 - Real-World Experience of First-Line Osimertinib in EGFR Mutated Non-Small Cell Lung Cancers from a Tertiary Cancer Center, India - 字舞流文

Real-World Experience of First-Line Osimertinib in EGFR Mutated Non-Small Cell Lung Cancers from a Tertiary Cancer Center, India

V. Noronha | N. Purandare | Atul Tiwari | N. Menon | Kunal Jobanputra | A. Singh | Mehak Trikha | K. Prabhash | Vijay Patil | Darshit Shah | Ahmad Ubharay | Trupti Pai | Rajiv Kumar | P. Chandrani | Minit J. Shah | Shashikant Yadav | Anuradha Majumdar | A. Janu